Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Tax Provisions: 2009-2024

Historic Tax Provisions for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to -$22,669.

  • Cumberland Pharmaceuticals' Tax Provisions fell 50.45% to $5,670 in Q3 2025 from the same period last year, while for Sep 2025 it was -$39,985, marking a year-over-year decrease of 167.45%. This contributed to the annual value of -$22,669 for FY2024, which is 149.53% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Tax Provisions stood at -$22,669 for FY2024, which was down 149.53% from $45,769 recorded in FY2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Tax Provisions peaked at $68,850 during FY2022, and registered a low of -$22,669 during FY2024.
  • Over the past 3 years, Cumberland Pharmaceuticals' median Tax Provisions value was $45,769 (recorded in 2023), while the average stood at $30,650.
  • In the last 5 years, Cumberland Pharmaceuticals' Tax Provisions surged by 170.48% in 2020 and then slumped by 149.53% in 2024.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Tax Provisions stood at $55,902 in 2020, then tumbled by 37.59% to $34,891 in 2021, then spiked by 97.33% to $68,850 in 2022, then tumbled by 33.52% to $45,769 in 2023, then tumbled by 149.53% to -$22,669 in 2024.